What Are The Barriers to HCV Treatment?

Video

Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.

Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.

Recent Videos
Related Content
Canada’s Prison Needle Exchange Program: Reducing Hepatitis C at a Profit

Canada’s Prison Needle Exchange Program: Reducing Hepatitis C at a Profit

Sophia Abene
December 19th 2024
Article
From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
August 1st 2024
Podcast
Investigational Hepatitis D Therapy Well-Tolerated, Safe for Chronic Disease at Week 48

Investigational Hepatitis D Therapy Well-Tolerated, Safe for Chronic Disease at Week 48

Tim Smith
December 15th 2024
Article
From Pathogen to Infectious Disease Diagnosis

From Pathogen to Infectious Disease Diagnosis

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
July 12th 2024
Podcast
Navigating Long COVID and ME/CFS Overlap

Navigating Long COVID and ME/CFS Overlap

Sophia Abene;Alba Azola, MD
December 12th 2024
Article
Hepatitis C and Homelessness: Assessing Risk Factors

Hepatitis C and Homelessness: Assessing Risk Factors

SASKIA V. POPESCU, PhD, MPH, MA, CIC
December 9th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.